NCODA
Hospitals and Health CareNew York, United States51-200 Employees
Advancing patient-centered cancer care through collaboration, education, and innovation.
Expanding Leadership NCODA has recently strengthened its leadership team by onboarding four distinguished professionals to its Executive Council, indicating a focus on strategic growth and increased industry influence, which presents opportunities for partnerships and targeted outreach.
Global Engagement The organization is hosting its inaugural Global Oncology & Haematology Congress in Dublin, demonstrating a commitment to international collaboration and widening its network, which could facilitate international sales and global distribution collaborations.
Innovative Initiatives NCODA launched the Oncology Insights Program in partnership with biotech analytics, signaling a focus on data-driven approaches in oncology care—an opportunity for offering advanced analytics, technology solutions, or education tools tailored to oncology providers.
Financial Stability With revenue estimates between $10 million and $25 million, NCODA exhibits solid financial health, making it a viable partner or client for sales in healthcare technology, clinical solutions, or service offerings aimed at oncology care improvements.
Strategic Focus The organization’s emphasis on patient-centered cancer care through collaboration and innovation suggests openness to products and services that enhance care coordination, patient engagement, and data management within oncology practices.
NCODA uses 8 technology products and services including Chart.js, jQuery, Slick, and more. Explore NCODA's tech stack below.
| NCODA Email Formats | Percentage |
| First.Last@ncoda.org | 47% |
| Last@ncoda.org | 5% |
| FirstLast@ncoda.org | 1% |
| First.Last@ncoda.org | 47% |
Hospitals and Health CareNew York, United States51-200 Employees
Advancing patient-centered cancer care through collaboration, education, and innovation.
NCODA's revenue is estimated to be in the range of $10M$25M
NCODA's revenue is estimated to be in the range of $10M$25M